Published in FASEB J on February 01, 2001
Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med (2006) 3.39
Modular Tissue Engineering: Engineering Biological Tissues from the Bottom Up. Soft Matter (2009) 1.93
Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev (2010) 1.76
Biohybrid thin films for measuring contractility in engineered cardiovascular muscle. Biomaterials (2010) 1.61
Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng (2007) 1.33
The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs (2011) 1.15
Self-organization and the self-assembling process in tissue engineering. Annu Rev Biomed Eng (2013) 1.04
Applying elastic fibre biology in vascular tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.01
Chitosan-based scaffolds for the support of smooth muscle constructs in intestinal tissue engineering. Biomaterials (2012) 1.00
Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng Part B Rev (2012) 0.91
The adventitia: the outs and ins of vascular disease. Cardiovasc Res (2007) 0.90
Hemodynamics and axial strain additively increase matrix remodeling and MMP-9, but not MMP-2, expression in arteries engineered by directed remodeling. Tissue Eng Part A (2009) 0.89
Electrospun vascular grafts with improved compliance matching to native vessels. J Biomed Mater Res B Appl Biomater (2014) 0.85
O2 level controls hematopoietic circulating progenitor cells differentiation into endothelial or smooth muscle cells. PLoS One (2009) 0.84
Tissue engineering of a collagen-based vascular media: Demonstration of functionality. Organogenesis (2011) 0.83
Differential and synergistic effects of mechanical stimulation and growth factor presentation on vascular wall function. Biomaterials (2013) 0.83
Effect of short-term organoid culture on the pharmaco-mechanical properties of rat extra- and intrapulmonary arteries. Br J Pharmacol (2005) 0.82
Tissue engineering of urinary bladder and urethra: advances from bench to patients. ScientificWorldJournal (2013) 0.80
The Tissue-Engineered Vascular Graft-Past, Present, and Future. Tissue Eng Part B Rev (2015) 0.79
Construction of tissue-engineered small-diameter vascular grafts in fibrin scaffolds in 30 days. Tissue Eng Part A (2014) 0.79
Quantifying light scattering with single-mode fiber -optic confocal microscopy. BMC Med Imaging (2009) 0.79
Advances in biomimetic regeneration of elastic matrix structures. Drug Deliv Transl Res (2012) 0.78
Biaxial biomechanical properties of self-assembly tissue-engineered blood vessels. J R Soc Interface (2010) 0.77
High compliance vascular grafts based on semi-interpenetrating networks. Macromol Mater Eng (2014) 0.75
Potential of Newborn and Adult Stem Cells for the Production of Vascular Constructs Using the Living Tissue Sheet Approach. Biomed Res Int (2015) 0.75
Cellular Self-Assembly with Microsphere Incorporation for Growth Factor Delivery Within Engineered Vascular Tissue Rings. Tissue Eng Part A (2016) 0.75
A completely biological tissue-engineered human blood vessel. FASEB J (1998) 5.82
Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol (1990) 2.83
Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J (1999) 2.75
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol (1986) 2.04
In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J (1998) 1.64
Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun (1990) 1.53
In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J Vasc Surg (1993) 1.49
Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol (1997) 1.41
Comparison of immunocytochemical and Holzer's methods for detection of acute and chronic gliosis in human postmortem material. J Neuropsychiatry Clin Neurosci (1992) 1.39
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Clin Cancer Res (1997) 1.36
Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene (2006) 1.35
Mechanisms of wound reepithelialization: hints from a tissue-engineered reconstructed skin to long-standing questions. FASEB J (2001) 1.28
Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol (2000) 1.25
The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol (1991) 1.23
Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension (2001) 1.19
Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr (1998) 1.19
Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol (1991) 1.19
Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. Eur J Pharmacol (1991) 1.13
Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries. J Physiol (1996) 1.13
Differential cytokeratin and alpha-fetoprotein expression in morphologically distinct epithelial cells emerging at the early stage of rat hepatocarcinogenesis. Cancer Res (1985) 1.12
Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim (1999) 1.12
Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aorta. Br J Pharmacol (1984) 1.11
Can we produce a human corneal equivalent by tissue engineering? Prog Retin Eye Res (2000) 1.11
Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiol Res (2008) 1.09
Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol (1991) 1.09
Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation (2001) 1.05
Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Biochem Pharmacol (1987) 1.05
Expression of heat shock proteins in mouse skin during wound healing. J Histochem Cytochem (1998) 1.05
Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res (2000) 1.05
Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by alpha-adrenoceptor agonists in rat aorta. J Cardiovasc Pharmacol (1991) 1.04
Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology (1999) 1.03
Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol (1992) 1.01
Role of wound healing myofibroblasts on re-epithelialization of human skin. Burns (2000) 1.00
A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br J Dermatol (2003) 1.00
Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity. Biochem Biophys Res Commun (1983) 0.99
Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat. Br J Pharmacol (2000) 0.99
Inhibition by papaverine of cGMP and cAMP phosphodiesterases from the rat heart. Biochem Pharmacol (1974) 0.98
Dependence of endotoxin-induced vascular hyporeactivity on extracellular L-arginine. Br J Pharmacol (1993) 0.98
L-arginine induces relaxation of small mesenteric arteries from endotoxin-treated rats. Eur J Pharmacol (1992) 0.97
Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol (1999) 0.97
Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction. J Cardiovasc Pharmacol (1990) 0.96
Dissociation between endothelium-mediated increases in tissue cGMP levels and modulation of aortic contractile responses. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.96
Establishment and characterization of a new cell line derived from a human primary breast carcinoma. Cancer Genet Cytogenet (2000) 0.95
Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts. Exp Cell Res (1998) 0.95
Alteration by lipopolysaccharide of the relationship between intracellular calcium levels and contraction in rat mesenteric artery. Br J Pharmacol (1996) 0.95
Calmodulin and its role in intracellular calcium regulation. Prog Neurobiol (1987) 0.94
Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta. Br J Pharmacol (1996) 0.94
Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res (1995) 0.93
An ubiquitous protein which regulates calcium-dependent cellular functions and calcium movements. Biochem Pharmacol (1981) 0.93
Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med (1992) 0.93
Bepridil and flunarizine as calmodulin inhibitors. Eur J Pharmacol (1984) 0.93
Tissue-engineered human skin substitutes developed from collagen-populated hydrated gels: clinical and fundamental applications. Med Biol Eng Comput (1998) 0.93
Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. Cardiovasc Hematol Agents Med Chem (2006) 0.92
Role of different epithelial cell types in liver ontogenesis, regeneration and neoplasia. In Vitro Cell Dev Biol (1989) 0.92
Mechanism of Ca2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries. Am J Physiol (1999) 0.92
Effects of cGMP on calcium handling in ATP-stimulated rat resistance arteries. Am J Physiol (1995) 0.92
Effects of acute liver injury on blood coagulation. J Thromb Haemost (2003) 0.92
Impaired antibody-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome. Clin Exp Immunol (1986) 0.91
Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries. Br J Pharmacol (1997) 0.91
Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms. Eur J Pharmacol (1990) 0.91
Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. J Surg Res (1994) 0.91
Optimization of murine keratinocyte culture for the production of graftable epidermal sheets. J Dermatol (1992) 0.91
Hyporeactivity of mesenteric vascular bed in endotoxin-treated rats. Eur J Pharmacol (1996) 0.91
Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation (1999) 0.90
Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia (1978) 0.90
Age-related decrease of in vitro isoproterenol-induced cyclic AMP accumulation in rat aorta. Eur J Pharmacol (1982) 0.90
Alterations in calcium stores in aortic myocytes from spontaneously hypertensive rats. Hypertension (1997) 0.90
Skin equivalent produced with human collagen. In Vitro Cell Dev Biol Anim (1995) 0.89
The type I keratin 19 possesses distinct and context-dependent assembly properties. J Biol Chem (1998) 0.89
Collagen fibril network and elastic system remodeling in a reconstructed skin transplanted on nude mice. Matrix Biol (2001) 0.89
Nitric oxide-related cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopolysaccharide-treated rat aorta. Br J Pharmacol (1998) 0.89
Prothrombin time to assess fulminant hepatic failure. Lancet (2002) 0.89
Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat. Br J Pharmacol (1996) 0.89
Improvement of human keratinocyte isolation and culture using thermolysin. Burns (1993) 0.89
A 16 kDa protein substrate for protein kinase C and its phosphorylation upon stimulation of vasopressin receptors in rat aortic myocytes. Biochem Biophys Res Commun (1987) 0.88
Functional characterization of postjunctional alpha-adrenoceptors in rat aorta. Eur J Pharmacol (1981) 0.88